Moraxella catarrahalis polynucleotides and polypeptides
    3.
    发明授权
    Moraxella catarrahalis polynucleotides and polypeptides 失效
    卡他莫拉沙星多核苷酸和多肽

    公开(公告)号:US06649171B1

    公开(公告)日:2003-11-18

    申请号:US09719190

    申请日:2000-12-08

    申请人: Joelle Thonnard

    发明人: Joelle Thonnard

    IPC分类号: A61K3902

    CPC分类号: C07K14/212 A61K39/00

    摘要: The invention provides BASB021 polypeptides and polynucleotides encoding BASB021 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.

    摘要翻译: 本发明提供了BASB021多肽和编码BASB021多肽的多核苷酸以及通过重组技术产生此类多肽的方法。 还提供诊断,预防和治疗用途。

    Vaccine composition
    7.
    发明申请
    Vaccine composition 审中-公开
    疫苗组成

    公开(公告)号:US20060204520A1

    公开(公告)日:2006-09-14

    申请号:US11434027

    申请日:2006-05-15

    IPC分类号: A61K39/02 C12N1/21

    摘要: The present invention relates to the field of novel, engineered Gram-negative bacterial strains that have improved outer-membrane vesicle shedding properties, and vaccine compositions comprising these bacteria or vesicles. The present invention provides a hyperblebbing Gram-negative bacterium which has been genetically modified by either or both processes selected from a group consisting of: down-regulation of expression of one or more tol genes; and mutation of one or more gene(s) encoding a protein comprising a peptidoglycan-associated site to attenuate the peptidoglycan-binding activity of the protein(s).

    摘要翻译: 本发明涉及具有改善的外膜囊泡脱落性质的新型工程革兰氏阴性菌株的领域,以及包含这些细菌或囊泡的疫苗组合物。 本发明提供了通过选自以下的一种或两种方法进行遗传修饰的超耐磨革兰氏阴性细菌:下调一个或多个tol基因的表达; 以及编码包含肽聚糖相关位点的蛋白质的一个或多个基因的突变以减弱所述蛋白质的肽聚糖结合活性。